These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27028276)

  • 1. Evidence for increased motor cortical facilitation and decreased inhibition in atypical depression.
    Veronezi BP; Moffa AH; Carvalho AF; Galhardoni R; Simis M; Benseñor IM; Lotufo PA; Machado-Vieira R; Daskalakis ZJ; Brunoni AR
    Acta Psychiatr Scand; 2016 Aug; 134(2):172-82. PubMed ID: 27028276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcranial magnetic stimulation neurophysiology of patients with major depressive disorder: a systematic review and meta-analysis.
    Kinjo M; Wada M; Nakajima S; Tsugawa S; Nakahara T; Blumberger DM; Mimura M; Noda Y
    Psychol Med; 2021 Jan; 51(1):1-10. PubMed ID: 33267920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressant-resistant depression is characterized by reduced short- and long-interval cortical inhibition.
    Jeng JS; Li CT; Lin HC; Tsai SJ; Bai YM; Su TP; Chang YW; Cheng CM
    Psychol Med; 2020 Jun; 50(8):1285-1291. PubMed ID: 31155020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for increased glutamatergic cortical facilitation in children and adolescents with major depressive disorder.
    Croarkin PE; Nakonezny PA; Husain MM; Melton T; Buyukdura JS; Kennard BD; Emslie GJ; Kozel FA; Daskalakis ZJ
    JAMA Psychiatry; 2013 Mar; 70(3):291-9. PubMed ID: 23303429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for pretreatment LICI deficits among depressed children and adolescents with nonresponse to fluoxetine.
    Croarkin PE; Nakonezny PA; Husain MM; Port JD; Melton T; Kennard BD; Emslie GJ; Kozel FA; Daskalakis ZJ
    Brain Stimul; 2014; 7(2):243-51. PubMed ID: 24360599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortical inhibitory and excitatory function in drug-naive generalized anxiety disorder.
    Li CT; Lu CF; Lin HC; Huang YZ; Juan CH; Su TP; Bai YM; Chen MH; Lin WC
    Brain Stimul; 2017; 10(3):604-608. PubMed ID: 28040450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Exploratory Study of Spectroscopic Glutamatergic Correlates of Cortical Excitability in Depressed Adolescents.
    Lewis CP; Port JD; Frye MA; Vande Voort JL; Ameis SH; Husain MM; Daskalakis ZJ; Croarkin PE
    Front Neural Circuits; 2016; 10():98. PubMed ID: 27965544
    [No Abstract]   [Full Text] [Related]  

  • 8. Prolonged cortical silent period among drug-naive subjects at ultra-high risk of psychosis.
    Tang Y; Zhang T; Edelman B; Zeng B; Zhao S; Li C; Zhuo K; Qian Z; Li H; Guo Q; Cui H; Zhu Y; Jiang L; Li C; Yu D; Wang J
    Schizophr Res; 2014 Dec; 160(1-3):124-30. PubMed ID: 25458861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global cortical hypoexcitability of the dominant hemisphere in major depressive disorder: A transcranial magnetic stimulation study.
    Khedr EM; Elserogy Y; Fawzy M; Elnoaman M; Galal AM
    Neurophysiol Clin; 2020 Jul; 50(3):175-183. PubMed ID: 32169427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impairments in motor-cortical inhibitory networks across recent-onset and chronic schizophrenia: a cross-sectional TMS Study.
    Strube W; Wobrock T; Bunse T; Palm U; Padberg F; Malchow B; Falkai P; Hasan A
    Behav Brain Res; 2014 May; 264():17-25. PubMed ID: 24509248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for cortical inhibitory and excitatory dysfunction in obsessive compulsive disorder.
    Richter MA; de Jesus DR; Hoppenbrouwers S; Daigle M; Deluce J; Ravindran LN; Fitzgerald PB; Daskalakis ZJ
    Neuropsychopharmacology; 2012 Apr; 37(5):1144-51. PubMed ID: 22169948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Glutamatergic and GABA
    Cash RF; Noda Y; Zomorrodi R; Radhu N; Farzan F; Rajji TK; Fitzgerald PB; Chen R; Daskalakis ZJ; Blumberger DM
    Neuropsychopharmacology; 2017 Jan; 42(2):502-511. PubMed ID: 27461082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A meta-analysis of cortical inhibition and excitability using transcranial magnetic stimulation in psychiatric disorders.
    Radhu N; de Jesus DR; Ravindran LN; Zanjani A; Fitzgerald PB; Daskalakis ZJ
    Clin Neurophysiol; 2013 Jul; 124(7):1309-20. PubMed ID: 23485366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced motor cortical inhibition in migraine: A blinded transcranial magnetic stimulation study.
    Neverdahl JP; Omland PM; Uglem M; Engstrøm M; Sand T
    Clin Neurophysiol; 2017 Dec; 128(12):2411-2418. PubMed ID: 29096214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cortical inhibitory and excitatory correlates of depression severity in children and adolescents.
    Lewis CP; Nakonezny PA; Ameis SH; Vande Voort JL; Husain MM; Emslie GJ; Daskalakis ZJ; Croarkin PE
    J Affect Disord; 2016 Jan; 190():566-575. PubMed ID: 26580570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of psychotropic drugs on cortical excitability of patients with major depressive disorders: A transcranial magnetic stimulation study.
    Khedr EM; Elserogy Y; Fawzy M; Abdelrahman AA; Galal AM; Noaman MM
    Psychiatry Res; 2020 Sep; 291():113287. PubMed ID: 32763548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysfunctions of cortical excitability in drug-naïve posttraumatic stress disorder patients.
    Rossi S; De Capua A; Tavanti M; Calossi S; Polizzotto NR; Mantovani A; Falzarano V; Bossini L; Passero S; Bartalini S; Ulivelli M
    Biol Psychiatry; 2009 Jul; 66(1):54-61. PubMed ID: 19368897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inter-hemispheric asymmetry of motor corticospinal excitability in major depression studied by transcranial magnetic stimulation.
    Lefaucheur JP; Lucas B; Andraud F; Hogrel JY; Bellivier F; Del Cul A; Rousseva A; Leboyer M; Paillère-Martinot ML
    J Psychiatr Res; 2008 Apr; 42(5):389-98. PubMed ID: 17449060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipsychotic treatment with quetiapine increases the cortical silent period.
    Frank E; Landgrebe M; Poeppl TB; Schecklmann M; Kreuzer PM; Prasser J; Rupprecht R; Eichhammer P; Hajak G; Langguth B
    Schizophr Res; 2014 Jun; 156(1):128-32. PubMed ID: 24794881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in thresholds for intracortical excitability in chronic stroke: more than just altered intracortical inhibition.
    Edwards JD; Meehan SK; Linsdell MA; Borich MR; Anbarani K; Jones PW; Ferris J; Boyd LA
    Restor Neurol Neurosci; 2013; 31(6):693-705. PubMed ID: 23963339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.